Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Intravenous Stemis™ in Elderly Subjects With Mild to Moderate Frailty Syndrome [Phase 1]

View source ↗

Summary

A Phase 1 study to evaluate the safety and tolerability of intravenous Stemis in elderly subjects with mild to moderate frailty syndrome; the trial is not yet r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Frailty Syndrome

Drugs mentioned

• Stemis

Snippet

Sponsor: Ji Yan Biomedical Co., Ltd. | Conditions: Frailty Syndrome | Phase 1 | Status: NOT_YET_RECRUITING